Trends in the Prevalence and Comorbidities of Diabetes Mellitus in Nursing Home Residents in the United States: 1995-2004

Divisions of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA.
Journal of the American Geriatrics Society (Impact Factor: 4.57). 04/2010; 58(4):724-30. DOI: 10.1111/j.1532-5415.2010.02786.x
Source: PubMed


To estimate trends in the prevalence and comorbidities of diabetes mellitus (DM) in U.S. nursing homes from 1995 to 2004.
SAS callable SUDAAN was used to adjust for the complex sample design and assess changes in prevalence of DM and comorbidities during the study period in the National Nursing Home Surveys. Trends were assessed using weighted least squares linear regression. Multiple logistic regressions were used to calculate predictive margins.
A continuing series of two-stage, cross-sectional probability national sampling surveys.
Residents aged 55 and older: 1995 (n=7,722), 1997 (n=7,717), 1999 (n=7,809), and 2004 (n=12,786).
DM and its comorbidities identified using a standard set of diagnosis codes.
The estimated crude prevalence of DM increased from 16.9% in 1995 to 26.4% in 2004 in male nursing home residents and from 16.1% to 22.2% in female residents (all P<.05). Male and female residents aged 85 and older and those with high functional impairment showed a significant increasing trend in DM (all P<.05). In people with DM, multivariate-adjusted prevalence of cardiovascular disease increased from 59.6% to 75.4% for men and from 68.1% to 78.7% for women (all P<.05). Prevalence of most other comorbidities did not increase significantly.
The burden of DM in residents of U.S. nursing homes has increased since 1995. This could be due to increasing DM prevalence in the general population or to changes in the population that nursing homes serve. Nursing home care practices may need to change to meet residents' changing needs.

Download full-text


Available from: William S Pearson, Oct 14, 2014
  • Source
    • "Comorbidity scores, the outcomes of this study, combine comorbid conditions identified in hospitalization or drug dispensation records into a single index score, weighted for disease severity (Schneeweiss & Maclure, 2000). These scores are used often as baseline controls for confounding effects in observational studies using administrative data (Deyo, Cherkin, & Ciol, 1992; Von Korff, Wagner, & Saunders, 1992) and sometimes to delineate trends of disease severity for a cohort of patients over time (Zhang et al., 2010). The Charlson comorbidity index (CCI) is constructed from a set of 19 conditions 1 indicated in hospitalizationbased ICD9/10 discharge diagnosis records; each condition is assigned a weight, with higher weights indicating greater severity (Needham, Scales, Laupacis, & 1 Nineteen diseases [and their weights] used in calculation of Charlson Comorbidity Index (CCI) are as follows (Quan et al. 2005): AIDS/HIV [w = 6], Metastatic Carcinoma [w = 6], Moderate or Severe Liver Disease [w = 3], Cancer [w = 2], Renal Disease [w = 2], Paraplegia and Hemiplegia [w = 2], Diabetes with complications [w = 2], Diabetes without complications [w = 1], Mild Liver Disease [w = 1], Peptic Ulcer Disease [w = 1], Connective Tissue Disease-Rheumatic Disease [w = 1], Chronic Pulmonary Disease [w = 1], Dementia [w = 1], Cerebrovascular Disease [w = 1], Peripheral Vascular Disease[w = 1], Congestive Heart Failure [w = 1], Myocardial Infarction [w = 1]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We described the changing characteristics and comorbidity levels of new patients into Methadone maintenance treatment (MMT) program in British Columbia, Canada, during its expansion period of 1998-2006. Analyses used administrative data. Generalized regression models were applied using Charlson Comorbidity Index (CCI) and Chronic Disease Score (CDS) as outcomes. 12,615 individuals initiated MMT during 1998-2006, while their odds of having moderate CCI (1 ≤ CCI ≤ 4) and mean CDS increased by 60% and 11%, respectively, after adjusting for confounders. MMT entrants were presented with progressively higher levels of comorbidity, independent of other characteristics. Future MMT policies should address higher levels of comorbidity among new patients.
    Substance Use &amp Misuse 06/2013; 48(8). DOI:10.3109/10826084.2013.800119 · 1.23 Impact Factor
  • Source
    • "in females, P < 0.05) [9]. For the oldest residents (aged ≥85 years), the prevalence increased from 13.1–19.5% in males (P = 0.02) and from 11.3–16.1% in females (P = 0.04) [9]. A more recent survey showed a further increase in the prevalence affecting approximately 32.8% of residents [10]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The prevalence of diabetes is increasing due to aging of the population and increasing obesity. In the developed world, there is an epidemiologic shift from diabetes being a disease of middle age to being a disease of older people due to increased life expectancy. In old age, diabetes is associated with high comorbidity burden and increased prevalence of geriatric syndromes in addition to the traditional vascular complications. Therefore, comprehensive geriatric assessment should be performed on initial diagnosis of diabetes. Due to the heterogeneous nature of older people with diabetes and variations in their functional status, comorbidities, and life expectancy, therapeutic interventions, and glycemic targets should be individualized taking into consideration patients' preferences and putting quality of life at the heart of their care plans.
    04/2013; 4(1). DOI:10.1007/s13300-013-0020-4
  • [Show abstract] [Hide abstract]
    ABSTRACT: The senescence is a life period characterized by two biologic effects: a diminution of adaptation capability, with more vulnerability (fragility), and increased mortality. This circumstance implies a peculiar way of being sick, with atypical symptomatic expressions, multimorbidity and functional decline. The functional level is an excellent marker of life expectancy, independently of clinical diagnostics. Therefore, in geriatric medicine diagnostic and therapeutic no decisions should been taken before knowing the functional level. Functional decline and the following disability are the main conditioning factors for admissions in long term care facilities. Diabetes in older people is a risk factor for functional decline. Elderly diabetic patients hospitalized in long term care facilities suffer more frequently neurodegenerative diseases, affective disorders, infections, skin ulcers and wounds, and malnutrition. This singularity implies that care plans and therapeutic targets should be different in the aged people than in the younger population, pointing out in improving the functional level and quality of life instead of increasing life expectancy.
    Avances en Diabetologia 10/2010; 26(5):326–330. DOI:10.1016/S1134-3230(10)65005-3
Show more